Evidence map›Paper›PMID 38973469›Full record

ReviewAnalytical methods : advancing methods and applications2024

Mass spectrometry-intensive top-down proteomics: an update on technology advancements and biomedical applications.

Tian Xu, Qianjie Wang, Qianyi Wang, Liangliang Sun

Abstract readReview
In one paragraph

Review in Analytical methods : advancing methods and applications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome.Journal of cardiovascular development and disease · 2026
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tian XuDepartment of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI 48824, USA. lsun@chemistry.msu.edu.
Qianjie WangDepartment of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI 48824, USA. lsun@chemistry.msu.edu.ORCID 0000-0002-1824-7111
Qianyi WangDepartment of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI 48824, USA. lsun@chemistry.msu.edu.ORCID 0009-0002-4405-7888
Liangliang SunDepartment of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, MI 48824, USA. lsun@chemistry.msu.edu.ORCID 0000-0001-8939-5042

Funding

Computational tools for top down mass spectrometry based proteoform identification and proteogenomicsR01GM118470 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Xiaowen Liu · 2016 to 2026
$2.7M
Quantitative top-down proteomics of human colorectal cancer cells and tumorsR01CA247863 · NCI · MICHIGAN STATE UNIVERSITY · PI HUMMON, AMANDA B., LIU, XIAOWEN · 2021 to 2025
$1.9M
Quantitative proteomics of Zebrafish embryos and blastomeresR01GM125991 · NIGMS · MICHIGAN STATE UNIVERSITY · PI SUN, LIANGLIANG · 2018 to 2022
$1.7M
NCI NIH HHS R01 CA247863NIGMS NIH HHS R01 GM118470NIGMS NIH HHS R01 GM125991
6 · The paper itself

Abstract

Proteoforms are all forms of protein molecules from the same gene because of variations at the DNA, RNA, and protein levels,

Indexed as

Mass SpectrometryProteomicsAnimalsBiomarkersComputational BiologyHumansProtein Processing, Post-TranslationalBiomarkers

Identifiers

PMID38973469
PMCPMC11257149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.